SG11202011365XA - Method for inducing differentiation into pluripotent stem cell-derived conjunctival cells - Google Patents
Method for inducing differentiation into pluripotent stem cell-derived conjunctival cellsInfo
- Publication number
- SG11202011365XA SG11202011365XA SG11202011365XA SG11202011365XA SG11202011365XA SG 11202011365X A SG11202011365X A SG 11202011365XA SG 11202011365X A SG11202011365X A SG 11202011365XA SG 11202011365X A SG11202011365X A SG 11202011365XA SG 11202011365X A SG11202011365X A SG 11202011365XA
- Authority
- SG
- Singapore
- Prior art keywords
- derived
- stem cell
- pluripotent stem
- inducing differentiation
- conjunctival cells
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5064—Endothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Developmental Biology & Embryology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018098954 | 2018-05-23 | ||
PCT/JP2019/020364 WO2019225672A1 (en) | 2018-05-23 | 2019-05-22 | Method for inducing conjunctival cells derived from pluripotent stem cells |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202011365XA true SG11202011365XA (en) | 2020-12-30 |
Family
ID=68616983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202011365XA SG11202011365XA (en) | 2018-05-23 | 2019-05-22 | Method for inducing differentiation into pluripotent stem cell-derived conjunctival cells |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210207087A1 (en) |
EP (1) | EP3783097A4 (en) |
JP (1) | JP7107595B2 (en) |
KR (1) | KR20210015789A (en) |
CN (1) | CN112189049B (en) |
AU (1) | AU2019273567A1 (en) |
SG (1) | SG11202011365XA (en) |
WO (1) | WO2019225672A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023190745A1 (en) * | 2022-04-01 | 2023-10-05 | 国立大学法人大阪大学 | Conjunctival epithelium marker and use for same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006129724A (en) * | 2004-11-02 | 2006-05-25 | Senju Pharmaceut Co Ltd | Method for screening compound having lacritin activity |
US20100184221A1 (en) * | 2007-07-13 | 2010-07-22 | Seiichi YOKOO | Method for isolation of cell, serum-free culture medium for cell, and method for culture of cell |
WO2016114285A1 (en) | 2015-01-15 | 2016-07-21 | 国立大学法人大阪大学 | Method for inducing differentiation of corneal epithelial cells from pluripotent stem cells |
-
2019
- 2019-05-22 SG SG11202011365XA patent/SG11202011365XA/en unknown
- 2019-05-22 EP EP19807067.4A patent/EP3783097A4/en active Pending
- 2019-05-22 KR KR1020207032930A patent/KR20210015789A/en active Search and Examination
- 2019-05-22 WO PCT/JP2019/020364 patent/WO2019225672A1/en active Application Filing
- 2019-05-22 US US17/057,021 patent/US20210207087A1/en active Pending
- 2019-05-22 AU AU2019273567A patent/AU2019273567A1/en active Pending
- 2019-05-22 CN CN201980034709.4A patent/CN112189049B/en active Active
- 2019-05-22 JP JP2020520350A patent/JP7107595B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2019273567A1 (en) | 2020-12-03 |
KR20210015789A (en) | 2021-02-10 |
JPWO2019225672A1 (en) | 2021-05-13 |
EP3783097A1 (en) | 2021-02-24 |
EP3783097A4 (en) | 2021-04-14 |
US20210207087A1 (en) | 2021-07-08 |
CN112189049B (en) | 2023-12-15 |
JP7107595B2 (en) | 2022-07-27 |
WO2019225672A1 (en) | 2019-11-28 |
CN112189049A (en) | 2021-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3491134A4 (en) | Human induced pluripotent stem cells for high efficiency genetic engineering | |
EP3246394A4 (en) | Method for inducing differentiation of corneal epithelial cells from pluripotent stem cells | |
IL250132A0 (en) | Method for inducing t cells for immunocytotheraphy from pluripotent stem cells | |
HK1212148A2 (en) | A method for the isolation and cultivation of mesenchymal stem cells from umbilical cords, and a method for the differentiation of the umbilical cord-derived mesenchymal stem cells into various mesenchymal tissues | |
EP3150705A4 (en) | Method for inducing myocardial differentiation of pluripotent stem cells using low-molecular compound | |
EP3540067A4 (en) | Method for delivering exogenous mitochondria into cells | |
EP3453753A4 (en) | Method for subculturing pluripotent stem cells | |
IL277025A (en) | Methods of enhancing stem cell differentiation into beta cells | |
EP3272858A4 (en) | Method for producing naïve pluripotent stem cells | |
EP3750985A4 (en) | Method for inducing differentiation of pluripotent stem cells into intestinal epithelial cells | |
IL282637A (en) | Methods for allogeneic hematopoietic stem cell transplantation | |
SG11201706886PA (en) | Cell culture method for mesenchymal stem cells | |
EP3702444A4 (en) | Method for inducing differentiation of pluripotent stem cells into hepatocytes | |
EP3196297A4 (en) | Method for producing cardiomyocyte population from pluripotent stem cells | |
EP3202896A4 (en) | Method for culturing pluripotent stem cells | |
EP3431584A4 (en) | Freezing method for aggregates of pluripotent stem cell-derived myocardial cells | |
IL281751A (en) | Methods for differentiating mesenchymal stem cells | |
IL263557B (en) | Differentiation of pluripotent stem cells into corneal cells | |
IL285083A (en) | Culture media for pluripotent stem cells | |
EP3587559A4 (en) | Production method for artificial pluripotent stem cells | |
EP3578640A4 (en) | Differentiation control method for pluripotent stem cells | |
PL3436568T3 (en) | Culture medium for pluripotent stem cells | |
IL294152A (en) | Method for culturing hematopoietic stem cells | |
IL274746A (en) | Method for culture of cells | |
EP3421598A4 (en) | Method for promoting differentiation of pluripotent stem cells by reducing undifferentiated state thereof |